AI assistant
AGRONOMICS LIMITED — Net Asset Value 2015
Nov 4, 2015
7474_rns_2015-11-04_58385cb3-4c16-4fc7-99e9-e80742e07e29.html
Net Asset Value
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4442E
Port Erin Biopharma Investments Ltd
04 November 2015
4 November 2015
Port Erin Biopharma Investments Limited
(the "Company")
Net Asset Value calculation to 30 September 2015
Jim Mellon, Chairman, commented: -
"The Net Asset Value ("NAV") calculation for the Company as at closing on 30 September 2015 was 10.04 pence per share, including un-invested cash of £67,542. The portfolio is valued under IFRS at bid price.
Net Assets stand at £2.3 million including Investments of £2.26 million. This quarter's NAV represents a decrease of 12.5% from the previous valuation of 11.47 pence per share, which included un-invested cash of £255,564. On this basis, no additional management fee is due to Shellbay Investments Limited.
The reported NAV to 30 September 2015 suffered due to some short-term share price fluctuations across the portfolio during the quarter. The company's three principal investments continue to show significant growth potential for the remainder of 2015 and beyond".
| Unaudited to 30 September 2015 £ | ||
| Fixed Assets | ||
| Investments | 2,268,245 | |
| Current Assets | ||
| Sundry Debtors | 17,230 | |
| Uninvested cash | 67,542 | |
| Current Liabilities | ||
| Creditors: amounts due | (24,185) | |
| 2,328,832 | ||
| Capital and Reserves | ||
| Share Capital | 23 | |
| Share Premium | 1,890,142 | |
| Reserves | 438,667 | |
| 2,328,832 | ||
| Shares in Issue | 23,195,558 | |
| Net Asset Value per share | 10.04 pence |
Portfolio Details
| Investments as at 30 September 2015 | Value | % of Total Portfolio | |
| Magna Biopharma Income Fund | £1,139,581 | 50.2% | |
| Plethora Solutions Holdings | £213,148 | 9.4% | |
| Summit Corporation | £417,264 | 18.4% | |
| Other quoted holdings | £254,920 | 11.2% | |
| Other unquoted holdings | £243,332 | 10.8% | |
| Total | £2,268,245 | 100.0% | |
For further information, please contact:
| Port Erin Biopharma Investments Limited |
Beaumont Cornish Limited | Peterhouse Capital Limited |
| The Company | Nomad | Broker |
| Denham Eke (+44) (0) 1624 639396 |
Roland Cornish (+44) (0) 207 628 3396 |
Lucy Williams (+44) (0) 207 469 0936 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
NAVFMMGMVFRGKZM